FI61688C - Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat Download PDF

Info

Publication number
FI61688C
FI61688C FI662/74A FI66274A FI61688C FI 61688 C FI61688 C FI 61688C FI 662/74 A FI662/74 A FI 662/74A FI 66274 A FI66274 A FI 66274A FI 61688 C FI61688 C FI 61688C
Authority
FI
Finland
Prior art keywords
mol
give
found
title compound
condensed
Prior art date
Application number
FI662/74A
Other languages
English (en)
Finnish (fi)
Other versions
FI61688B (fi
Inventor
John Hamilton Sellstedt
Charles John Guinosso
Albert John Begany
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of FI61688B publication Critical patent/FI61688B/fi
Publication of FI61688C publication Critical patent/FI61688C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI662/74A 1973-03-23 1974-03-06 Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat FI61688C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34446673A 1973-03-23 1973-03-23
US34446673 1973-03-23

Publications (2)

Publication Number Publication Date
FI61688B FI61688B (fi) 1982-05-31
FI61688C true FI61688C (fi) 1982-09-10

Family

ID=23350656

Family Applications (1)

Application Number Title Priority Date Filing Date
FI662/74A FI61688C (fi) 1973-03-23 1974-03-06 Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat

Country Status (14)

Country Link
JP (1) JPS5920664B2 (xx)
AR (1) AR207563A1 (xx)
BE (1) BE812743A (xx)
CA (1) CA1034118A (xx)
CH (1) CH612914A5 (xx)
DE (1) DE2413966A1 (xx)
EG (1) EG11281A (xx)
ES (1) ES424514A1 (xx)
FI (1) FI61688C (xx)
FR (1) FR2222097B1 (xx)
NL (1) NL7403843A (xx)
PH (1) PH14870A (xx)
SE (1) SE411898B (xx)
ZA (1) ZA74635B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011337A (en) * 1975-07-07 1977-03-08 The Upjohn Company Oxamide-oxamic compounds, compositions and methods of use
US4172147A (en) * 1976-11-17 1979-10-23 The Upjohn Company 3,5-Dinitro oxanilic acid ester compounds, compositions and methods
US4119783A (en) * 1977-02-18 1978-10-10 The Upjohn Company 3'Lower alkylcarbonyl oxanilic acid esters
NL7810634A (nl) * 1977-10-28 1979-05-02 May & Baker Ltd Tetrazool-derivaten.
DE3027527A1 (de) 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3027528A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Ueberbrueckte thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2546885B1 (fr) * 1983-06-06 1986-02-07 Fabre Sa Pierre Oxamates d'anthranilates fonctionnalises utiles comme medicaments dans le traitement des dermatoses inflammatoires
JPS6112268U (ja) * 1984-06-25 1986-01-24 松下電工株式会社 プリント配線基板
JPH072697B2 (ja) * 1985-05-24 1995-01-18 久光製薬株式会社 新規なオキサニル酸誘導体
US6225329B1 (en) 1998-03-12 2001-05-01 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPases)
AU2713699A (en) * 1998-03-12 1999-09-27 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
ES2395682T3 (es) 2007-08-20 2013-02-14 Symrise Ag Derivados de ácido oxálico y su uso como principios activos refrescantes fisiológicos

Also Published As

Publication number Publication date
FR2222097B1 (xx) 1978-06-30
CA1034118A (en) 1978-07-04
ES424514A1 (es) 1976-06-16
JPS49135929A (xx) 1974-12-27
FR2222097A1 (xx) 1974-10-18
FI61688B (fi) 1982-05-31
PH14870A (en) 1982-01-08
NL7403843A (xx) 1974-09-25
AR207563A1 (es) 1976-10-15
SE411898B (sv) 1980-02-11
ZA74635B (en) 1975-09-24
DE2413966A1 (de) 1974-09-26
AU6575374A (en) 1975-08-21
BE812743A (fr) 1974-09-23
JPS5920664B2 (ja) 1984-05-15
EG11281A (en) 1977-05-31
CH612914A5 (en) 1979-08-31

Similar Documents

Publication Publication Date Title
US3966965A (en) Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions
FI61688C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat
US4069343A (en) Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions
US4057632A (en) Method of treatment using tetrazole-5-carboxamide derivatives
US4036837A (en) 2 Alkoxyoxamoyl-pyrazines
US4054666A (en) Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US4110453A (en) N-(2-pyrimidinyl)1h-(or 2h)tetrazole-5-carboxamide derivatives for the prevention of immediate type hypersensitivity reactions
JPS5946220B2 (ja) 複素環化合物の製法
US4044144A (en) 1H-tetrazole-5-carboxamides
US4082751A (en) Therapeutic agents
US4096153A (en) Arylene-bis-tetrazole-5-carboxamides
US4160100A (en) Oxamic acid derivatives
US4191840A (en) Oxamic acid derivatives
US3953461A (en) Amino derivatives of thiazolo[5,4-b]pyridine-6-carboxylic acids and esters
US4154961A (en) Oxamic acid derivatives
US3937719A (en) (4-oxo-4h-1-benzopyran-2-yl)-oxamic acid, salts and esters anti-allergic agents
CA1071203A (en) Aromatic amidines as antiviral agents in animals
US4625028A (en) 6-aryluracils and selected novel intermediates used in the preparation thereof
US4110458A (en) N-(pyridyl) oxamic acid derivatives
US4171367A (en) Pyrazolyl amino imidazolines
US4054657A (en) Pyrimidinyl oxamic acids and esters, and compositions and methods for the suppression of allergic manifestations
EP0064385B1 (en) 2,6-diaryl-pyridinecarboxylic acids and their therapeutic utility
US4054661A (en) Pyridyl oxamic acid derivatives and use in the prevention of allergic reactions
US4087606A (en) 2-Cyano-3- or 4-(substituted amino)oxanilic acid derivatives
US4032652A (en) Substituted 2h-pyran-2,6(3h)-dione derivatives, pharmaceutical compositions comprising such derivatives and methods of inhibiting the antigen-antibody reaction